Empery Asset Management LP 13D and 13G filings for Kiromic BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-01-12 10:02 am Purchase |
2022-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management LP | 163,268 9.990% |
163,268![]() (New Position) |
Filing |
2022-01-13 10:37 am Sale |
2021-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management LP | 0 0.000% |
-33,333![]() (Position Closed) |
Filing |
2021-07-06 10:00 am Purchase |
2021-06-29 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management LP | 33,333 6.500% |
33,333![]() (New Position) |
Filing |